Jun 30, 2019

Gilead Sciences Q2 2019 Earnings Report

Total Revenue
$5.69B
Previous year: $5.65B
+0.7%
EPS
$1.82
Previous year: $1.91
-4.7%
Gross Profit
$4.69B
Previous year: $4.45B
+5.2%
Cash and Equivalents
$11.2B
Previous year: $13.2B
-15.1%
Free Cash Flow
$1.9B
Previous year: $1.28B
+49.1%
Total Assets
$63.2B
Previous year: $65.4B
-3.3%

Gilead Sciences

Gilead Sciences

Gilead Sciences Revenue by Segment

Gilead Sciences Revenue by Geographic Location